# Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mavoglurant-in-fragile-x-syndrome-results-of-two-randomized-double-blind-placebo/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elizabeth Berry‐Kravis,Vincent des Portes,Randi J. Hagerman,Sébastien Jacquemont,Perrine Charles,Jeannie Visootsak,Marc Brinkman,K. Rérat,Barbara Koumaras,Liansheng Zhu,Gottfried Maria Barth,Thomas Jaecklin,George Apostol,Florian von Raison |
| Citations | 264 |
| DOI | 10.1126/scitranslmed.aab4109 |
| Fields | Biochemistry, Genetics and Molecular Biology,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2237631658 |
| PMID | 26764156 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Vincent des Portes](https://scholariq.org/researchers/vincent-des-portes/)

## Paper primary topic

- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)

## Paper topics

- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Autism Spectrum Disorder Research](https://scholariq.org/topics/autism-spectrum-disorder-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.